Elevated estrogen receptor β expression in triple negative breast cancer cells is associated with sensitivity to doxorubicin by inhibiting the PI3K/AKT/mTOR signaling pathway

Based on its pathological characteristics, breast cancer is a highly heterogeneous disease. Triple negative breast cancer (TNBC) is an aggressive subtype, and due to a lack of effective therapeutic targets, patients with TNBC do not significantly benefit from endocrine or anti-HER2 therapy. Conventi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Shanshan, Fan, Peizhi, Wang, Mengchuan, Zhang, Chaojie, Jiang, Yu, Huang, Shulin, Fang, Meng, He, Zili, Wu, Aiguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388322/
https://www.ncbi.nlm.nih.gov/pubmed/32742395
http://dx.doi.org/10.3892/etm.2020.8809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388322/
https://www.ncbi.nlm.nih.gov/pubmed/32742395
http://dx.doi.org/10.3892/etm.2020.8809

Ejemplares similares